Novavax Archives -

US panel backs Omicron-targeting vaccines for booster campaigns

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, fda, GlaxoSmithKline, Moderna, Novavax, Omicron, Pfizer, regulatory, variant 0 Comment

Future booster campaigns against COVID-19 should include vaccines with a component targeting the Omicron variant of SARS-CoV-2, according

US panel backs Omicron-targeting vaccines for booster campaigns

https://pharmaphorum.com/news/us-panel-backs-omicron-targeting-vaccines-for-booster-campaigns/

Data hackathon analyses truth behind ‘game-changer’ COVID vaccine

Market Access/ News/ News

Novavax COVID jab ‘could save UK money on boosters’

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, MHRA, Novavax, UK 0 Comment

The approval of Novavax’ COVID-19 vaccine in Great Britain could help the country save a “considerable amount of

Novavax COVID jab ‘could save UK money on boosters’

https://pharmaphorum.com/news/novavax-covid-jab-could-save-uk-money-on-boosters/

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

News/ News/ Patients

COVID booster shots increase immunity, trial shows

Joy Persaud AstraZeneca, BioNTech, coronavirus, COVID-19, COVID-19 vaccine, CureVac, Janssen, Moderna, NHS, Novavax, Omicron, Pfizer, UK, Valneva 0 Comment

A trial of booster vaccinations to protect against COVID-19 has shown that the jab significantly strengthens the body’s

COVID booster shots increase immunity, trial shows

https://pharmaphorum.com/news/covid-booster-shots-increase-immunity-trial-shows/

News/ News/ R&D

Pharma pledges rapid response to Omicron COVID variant

Phil Taylor AstraZeneca, BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Novavax, Omicron, Pfizer, Valneva, variant 0 Comment

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened

Pharma pledges rapid response to Omicron COVID variant

https://pharmaphorum.com/news/pharma-pledges-rapid-response-to-omicron-covid-variant/

Market Access/ News/ News

Novavax gets first authorisation for its COVID-19 jab

Phil Taylor access, coronavirus, COVID-19, COVID-19 vaccine, Indonesia, Novavax 0 Comment

Novavax has been granted its first emergency use authorisation in Indonesia for COVID-19 vaccine NVX-CoV2373, and expects other

Novavax gets first authorisation for its COVID-19 jab

https://pharmaphorum.com/news/novavax-gets-first-authorisation-for-its-covid-19-jab/

Market Access/ News/ News

Novavax files its COVID jab to WHO for emergency use listing

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, Novavax, Serum Institute of India, WHO 0 Comment

Novavax and its partner Serum Institute of India have applied to the World Health Organization for an emergency

Novavax files its COVID jab to WHO for emergency use listing

https://pharmaphorum.com/news/novavax-files-its-covid-jab-to-who-for-emergency-use-listing/

Coronavirus vaccine: how pharma is picking up the pace

News/ News/ Patients

Amnesty says COVID jab producers are causing human rights crisis

Phil Taylor amnesty international, AstraZeneca, BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Johnson & Johnson, Moderna, Novavax, Pfizer 0 Comment

Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies for not agreeing

Amnesty says COVID jab producers are causing human rights crisis

https://pharmaphorum.com/news/amnesty-says-covid-jab-producers-are-causing-human-rights-crisis/

News/ News/ R&D

Novavax unveils phase 3 COVID jab data, but has it missed the boat in US?

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, fda, Novavax 0 Comment

The top-line phase 3 data for Novavax’ COVID-19 vaccine look good, with a 90% overall efficacy rate, but

Novavax unveils phase 3 COVID jab data, but has it missed the boat in US?

https://pharmaphorum.com/news/novavax-unveils-phase-3-covid-jab-data-but-has-it-missed-the-boat-in-us/

News/ News/ Patients

UK booster trial will test value of third COVID jab dose

Phil Taylor AstraZeneca, BioNTech, coronavirus, coronavirus vaccine, COVID-19, CureVac, Janssen, Moderna, Novavax, Pfizer, UK, Valneva 0 Comment

All seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will

UK booster trial will test value of third COVID jab dose

https://pharmaphorum.com/news/uk-booster-trial-will-test-value-of-third-covid-jab-dose/

Trending

Novavax

Login